Common Contracts

AGREEMENT AND PLAN OF MERGER BY AND AMONG EMERGENT BIOSOLUTIONS INC., 30333 INC. AND TRUBION PHARMACEUTICALS, INC. Dated as of August 12, 2010

Merger Agreement • August 13th, 2010 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Merger Agreement
• Filed
  August 13th, 2010
• Company
  Trubion Pharmaceuticals, Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

(together with all annexes, letters, schedules and exhibits hereto, this “Agreement”), dated as of August 12, 2010, is by and among Emergent BioSolutions Inc. a Delaware corporation (“Parent”), 35406 LLC, a Delaware limited liability company and wholly owned direct subsidiary of Parent (sometimes referred to herein as the “LLC” or the “Final Surviving Entity”), 30333 Inc., a Delaware corporation and wholly owned indirect subsidiary of Parent (sometimes referred to herein as “Merger Sub”), and Trubion Pharmaceuticals, Inc. a Delaware corporation (the “Company” or the “Interim Surviving Corporation”).

AGREEMENT AND PLAN OF MERGER

Merger Agreement • August 13th, 2010 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Merger Agreement
• Filed
  August 13th, 2010
• Company
  Emergent BioSolutions Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (together with all annexes, letters, schedules and exhibits hereto, this “Agreement”), dated as of August 12, 2010, is by and among Emergent BioSolutions Inc. a Delaware corporation (“Parent”), 35406 LLC, a Delaware limited liability company and wholly owned direct subsidiary of Parent (sometimes referred to herein as the “LLC” or the “Final Surviving Entity”), 30333 Inc., a Delaware corporation and wholly owned indirect subsidiary of Parent (sometimes referred to herein as “Merger Sub”), and Trubion Pharmaceuticals, Inc. a Delaware corporation (the “Company” or the “Interim Surviving Corporation”).